Teva Recalls ADRUCIL Fluorouracil Injection Due to Particulate Matter
Teva Pharmaceuticals USA is recalling ADRUCIL (fluorouracil injection) vials due to the presence of silicone rubber and fluorouracil crystals in the solution.
- Product
- ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).
- Category
- Drug
- Distribution
- Distributed nationwide